Comparative analysis of the safety and tolerability of fixed-dose artesunate/amodiaquine versus artemether/lumefantrine combinations for uncomplicated falciparum malaria in pregnancy: a randomized open label study

References

• BremanJGAlilioMSWhiteNJDefining and Defeating the Intolerable Burden of Malaria III: Progress and Perspectives: Supplement to Volume 77(6) of American Journal of Tropical Medicine and HygieneNorthbrook, ILAmerican Society of Tropical Medicine and Hygiene2007
   Google Scholar
• EyasuMAntimalarial drug resistance: in the past, current status and future perspectivesBr J Pharmacol Toxicol201561115
   Google Scholar
• O’NeillPMPosnerGHA medicinal chemistry perspective on artemisinin and related endoperoxidesJ Med Chem200447122945296415163175
   PubMed Web of Science ®Google Scholar
• AngusBNovel anti-malarial combinations and their toxicityExpert Rev Clin Pharmacol20147329931624716844
   PubMed Web of Science ®Google Scholar
• RosenthalPJArtesunate for the treatment of severe Falciparum malariaN Engl J Med20083581829183618434652
   PubMed Web of Science ®Google Scholar
• DubeSKPandaPSAgrawalGRSinghDKAnaphylaxis to artesunate?Indian J Crit Care Med2012161555722557837
   PubMedGoogle Scholar
• Federal Ministry of Health Nigeria (FMOH)National Antimalarial Treatment Policy2005131 Available from: http://apps.who.int/medicinedocs/documents/s18401en/s18401en.pdfAccessed August 14, 2016
   Google Scholar
• WoodrowCJHaynesRKKrishnaSArtemisininsPostgrad Med J200581952717815701735
   PubMed Web of Science ®Google Scholar
• ThomasFErhartAD’AlessandroUAmodiaquine in pregnancy: can amodiaquine be used safely during pregnancy?Lancet Infect Dis20044423523915050942
   PubMed Web of Science ®Google Scholar
• DiagneNRogierCSokhnaCSIncreased susceptibility to malaria during the early postpartum periodN Engl J Med2000343959860310965006
   PubMed Web of Science ®Google Scholar
• TionoABGuelbeogoMWSagnonNFDynamics of malaria transmission and susceptibility to clinical malaria episodes following treatment of Plasmodium falciparum asymptomatic carriers: results of a cluster-randomized study of community-wide screening and treatment, and a parallel entomology studyBMC Infect Dis20131353524215306
   PubMed Web of Science ®Google Scholar
• World Health OrganizationGuidelines for the Treatment of Malaria2nd edGenevaWHO20101921 http://whqlibdoc.who.int/publications/2010/9789241547925_eng.pdfAccessed June 21, 2016
   Google Scholar
• SchulzKFAltmanDGMoherDCONSORT GroupCONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trialsBMJ2010340c33220332509
   PubMed Web of Science ®Google Scholar
• Miri-DasheTOsaweSTokdungMComprehensive reference ranges for hematology and clinical chemistry laboratory parameters derived from normal Nigerian adultsPLoS One201495e9391924832127
   PubMed Web of Science ®Google Scholar
• AjayiNAUkwajaKNPossible artemisinin based combination therapy-resistant malaria in Nigeria: a report of three casesRev Soc Bras Med Trop201346452552723982103
   PubMed Web of Science ®Google Scholar
• WHOGlobal Malaria ProgramArtemisinin and Artemisinin-Based Combination Therapy Resistance: Status ReportWHO/HTM/GMP/2016.5 Available from: https://www.apps.who.int/iris/bitstream/10665/208820/1/WHO_HTM_GMP_2016.5_eng.pdfAccessed August 14, 2016
   Google Scholar
• MishraSKSinghPRathSKA study of the toxicity and differential gene expression in murine liver following exposure to anti-malarial drugs: amodiaquine and sulfadoxine-pyrimethamineMalar J20111010921529379
   PubMed Web of Science ®Google Scholar
• NostenFWhiteNJArtemisinin-based combination treatment of fal-ciparum malariaAm J Trop Med Hyg200777Suppl 618119218165491
   PubMed Web of Science ®Google Scholar
• United States National Library of MedicineAmodiaquine: clinical and research information on drug induced liver injury Available from: https://www.livertox.nih.gov/amodiaquine.htmlAccessed September 24, 2016
   Google Scholar
• TaylorWRWhiteNJAntimalarial drug toxicity a reviewDrug Saf2004271256114720085
   PubMed Web of Science ®Google Scholar
• UmohIUEkanamTBEluwaMAFetal Hepatorenal toxicity of artemether/lumefantrine (COARTEMR) in second trimester of pregnancy of Albino ratsEJPMR201742240246
   Google Scholar
• UgianEADasofunjoKNwangwaJNEffect of artemisinin-based combination therapy on some selected liver function indices of pregnant Wistar Albino ratsJ Appl Pharm Sci201339152154
   Google Scholar
• KhandaveSSJoshiSSSawantSVOnkarSVEvaluation of bio-equivalence and cardio-hepatic safety of a single dose of fixed dose combination of artemether/lumefantrineJ Bioequiv Availab201024081085
   Google Scholar
• EffiongOOUdoNVNsaAAComparative effects of two antimalarial drugs (P-Alaxin & Coartem) on serum electrolytes and serum enzymes in Albino Wistar ratsRes J Pharm Biol Chem Sci (RJPBCS)2014515463
   Google Scholar
• KocharDKAgarwalPKocharSKHepatocyte dysfunction and hepatic encephalopathy in Plasmodium falciparum malariaQJM200396750551212881593
   PubMed Web of Science ®Google Scholar
• DesaiMter KuileFONostenFEpidemiology and burden of malaria in pregnancyLancet Infect Dis2007729310417251080
   PubMed Web of Science ®Google Scholar
• HuynhBTCottrellGCotMBriandVBurden of malaria in early pregnancy: a neglected problem?Clin Infect Dis201560459860425362205
   PubMed Web of Science ®Google Scholar
• OsorioLGonzalezIOlliaroPTaylorWRArtemisinin based combination therapy for uncomplicated Plasmodium falciparum malaria in ColombiaMalar J200762517328806
   PubMed Web of Science ®Google Scholar
• OtuechereCAEdeworGKaleOEEkorMSubacute therapeutic dosing of AL and AA combinations preserves plasma cholesterol, renal antioxidant status and organ weights in ratsMalar Res Treat20122579865
   Google Scholar
• YuliangWZejianWHaulinSMingYKexieanTThe hypolipidemic effect of artesunate and ursolic acid in ratsPak J Pharm Sci201528387187426004719
   PubMed Web of Science ®Google Scholar
• OsunugaIOOsunugaOAOsonugaAOnadekoAAOsunugaAAEffect of the artemether on hematological parameters of healthy and uninfected adult Wistar ratsAsian Pac J Trop Biomed20122649349523569957
   PubMedGoogle Scholar
• OfemOEEssienNMOkonUAEffects of chloroquine and coartem on hematological parameters in ratsAfr J Biomed Res20131613946
   Google Scholar
• EgunsolaOOshikoyaKAComparative safety of artemether-lumefantrine and other artemisinin-based combination in children: a systemic reviewMalar J20131238524175945
   PubMed Web of Science ®Google Scholar
• SchrammBValehPBaudinETolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combination for the treatment of uncomplicated P. falciparum malaria: two open-label randomized trials in Nimba County LiberiaMalar J20131225023866736
   PubMed Web of Science ®Google Scholar
• AdjeiGOKurtzhalsJARodriguesOPAmodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-upMalar J2008712718620577
   PubMed Web of Science ®Google Scholar
• FayeBOffiananATNdiayeJLEfficacy and tolerability of artesunate-amodiaquine (Camoquine+) versus artemether-lumefantrine against uncomplicated P. falciparum malaria: multisite trial in Senegal and Ivory CoastTrop Med Int Health201015560861320214761
   PubMed Web of Science ®Google Scholar
• NdiayeJLFayeBGueyeARepeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trialMalar J20111023721838909
   PubMed Web of Science ®Google Scholar
• NdiayeJLRandrianaRMSagaraIRandomized, multicentre assessment of the efficacy and safety of ASAQ–a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malariaMalar J2009812519505304
   PubMed Web of Science ®Google Scholar
• ManyandoCKayentaoKD’AllessandroUOkaforHUJumaEHamedKA systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancyMalar J20121114122548983
   PubMed Web of Science ®Google Scholar
• Ohaju-ObodoJOIribhogbeOIExtent of pharmacovigilance among resident doctors in Edo and Lagos states of NigeriaPharmacoepidemiol Drug Saf201019219119520014358
   PubMed Web of Science ®Google Scholar
• OshikoyaKAAdverse event monitoring of artemisinin combination therapy in Nigeria: the challenges and limitation of the studyWest Afr J Med201029422122420931507
   PubMedGoogle Scholar
• PalleriaCLeporiniCClumirnSLimitations and obstacles of the spontaneous adverse drug reaction reporting: two challenging case reportsJ Pharmacol Pharmacother20134Suppl 1S66S7224347986
   PubMedGoogle Scholar